FEXOFAST 180 MG

Poland

The 120 mg version helps relieve symptoms of hay fever (sneezing, itchy and runny nose, nasal congestion, itchy, watery, and red eyes). The 180 mg version is intended to relieve skin redness, swelling, and itching in chronic idiopathic urticaria.

Brand name FEXOFAST 180 MG
Dosage form tablets, film-coated
Active substance / Dosage
Prescription type Prescription only
ATC code
Registration number 100182050
FEXOFAST 180 MG tablets, film-coated

Frequently asked questions

How should Fexofast 120 mg or Fexofast 180 mg be taken?

Tablets should be taken once daily, before a meal, with water. Always follow your doctor's instructions.

When should you not use this medicine?

Do not take this medicine if you are allergic to fexofenadine or any of the ingredients of the medicine. Consult a doctor before use if you are elderly or have kidney, liver, or heart problems.

Can other medicines be taken with Fexofast?

When taking stomach medicines containing aluminum or magnesium, a gap of approximately 2 hours should be maintained from the administration of the medicine. You should also inform your doctor if you are taking erythromycin, ketoconazole, or lopinavir with ritonavir, as these may increase the concentration of the active substance in the body.

What are the possible side effects of Fexofast 120 mg or Fexofast 180 mg?

Headaches, drowsiness, nausea, and dizziness may occur frequently. Also unknown are, among others, sleep problems, nervousness, heart palpitations, diarrhea, rash, and severe allergic reactions such as facial swelling or difficulty breathing (in such a case, stop use immediately and seek medical attention).

What should be done in case of overdose?

In case of taking more than the recommended dose, contact a doctor immediately or go to the nearest hospital emergency department. Symptoms of overdose may include dizziness, drowsiness, fatigue, and dry mouth.

Can the medicine be used during pregnancy or breastfeeding?

During pregnancy, the medicine should only be used if a doctor deems it absolutely necessary. Use of the medicine is not recommended in breastfeeding women.

Instructions for use

Package leaflet: Information for the patient

Fexofast 120 mg, 120 mg, film-coated tablets
Fexofast 180 mg, 180 mg, film-coated tablets
Fexofenadini hydrochloridum
Please read all of this leaflet carefully before taking this medicine, because it contains
important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm someone else, even if their symptoms are the same as yours.
  • If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Contents of the leaflet

  1. What Fexofast 120 mg and Fexofast 180 mg are and what they are used for
  2. Important information before taking Fexofast 120 mg or Fexofast 180 mg
  3. How to take Fexofast 120 mg or Fexofast 180 mg
  4. Possible side effects
  5. How to store Fexofast 120 mg and Fexofast 180 mg
  6. Contents of the pack and other information

1. What Fexofast 120 mg and Fexofast 180 mg are and what they are used for

The active substance in this medicine, fexofenadine hydrochloride, belongs to a group of medicines called antihistamines.

Fexofast 120 mg tablets are indicated for use in adults and adolescents aged 12 years and older to relieve symptoms such as sneezing, itchy nose, runny nose or blocked nose, and itchy, watery and red eyes, which are usually associated with hay fever (seasonal allergic rhinitis).

Fexofast 180 mg tablets are indicated for use in adults and adolescents aged 12 years and older to relieve symptoms such as redness, swelling and itching of the skin associated with a chronic allergic skin condition called chronic idiopathic urticaria.

2. Important information before taking Fexofast 120 mg or Fexofast 180 mg

When not to take Fexofast 120 mg or Fexofast 180 mg

  • if you are allergic to fexofenadine or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions
Before taking Fexofast 120 mg or Fexofast 180 mg, talk to your doctor or pharmacist.
Exercise particular caution:

  • if you are elderly,
  • if you have kidney or liver problems,
  • if you have heart problems now or have ever had them, because these medicines may cause rapid or irregular heartbeat.

If any of the above apply to you, or if you are unsure, speak to your doctor before taking Fexofast 120 mg or Fexofast 180 mg.

Fexofast 120 mg or Fexofast 180 mg and other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
If you are taking antacids containing aluminium or magnesium, it is recommended to leave an interval of about 2 hours between taking this medicine and taking Fexofast 120 mg or Fexofast 180 mg. Antacids may reduce the amount of Fexofast 120 mg or Fexofast 180 mg absorbed and thus affect its action.
If you take fexofenadine together with erythromycin or ketoconazole, or with a single dose of lopinavir with ritonavir, the plasma concentration of fexofenadine may increase. This may lead to an increased risk of side effects.

Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy
Fexofast 120 mg and Fexofast 180 mg should only be used during pregnancy if your doctor considers it absolutely necessary.

Breastfeeding
Fexofast 120 mg and Fexofast 180 mg are not recommended for use in women who are breastfeeding.

Driving and using machines
It is unlikely that Fexofast 120 mg or Fexofast 180 mg will affect your ability to drive or use machines. However, before driving or operating machinery, make sure that the medicine does not cause drowsiness or dizziness.

The medicine contains less than 1 mmol (23 mg) of sodium per Fexofast 120 mg or Fexofast 180 mg film-coated tablet, i.e. it is considered to be "sodium-free".

3. How to use Fexofast 120 mg or Fexofast 180 mg

This medicine should always be used as directed by the physician. If in doubt, consult your
doctor or pharmacist.
Recommended dose
For adults and children aged 12 years and older
Fexofast 120 mg, tablets
The usual dose is one tablet (120 mg) once daily.
Fexofast 180 mg, tablets
The usual dose is one tablet (180 mg) once daily.
Method of administration
The tablets should be taken before a meal, with water.
Taking more than the recommended dose of Fexofast 120 mg or Fexofast 180 mg
If more than the recommended dose of Fexofast 120 mg or Fexofast 180 mg has been taken, contact
a doctor immediately or go immediately to the emergency room of the nearest hospital.
Symptoms of overdose in adults include: dizziness, drowsiness, fatigue, and dry mouth.
Missing a dose of Fexofast 120 mg or Fexofast 180 mg
Do not take a double dose to make up for a missed dose. Take the next dose as usual.
Stopping treatment with Fexofast 120 mg or Fexofast 180 mg
Consult your doctor if you plan to discontinue treatment with Fexofast 120 mg or Fexofast 180 mg.
If treatment is stopped earlier than recommended by the doctor, symptoms of the disease may return.
If you have any further doubts about the use of this medicine, consult your doctor or pharmacist.

4. Possible adverse reactions

Like all medicines, this medicine can cause adverse reactions, although not everyone will experience them.
If symptoms of a severe allergic reaction occur (swelling of the face, lips, tongue or throat, and
difficulty breathing), the medicine must be discontinued immediately and medical advice must be sought without delay.
The frequency of the possible adverse reactions listed below is defined as follows:

  • common (occur in 1 to 10 people out of 100);
  • uncommon (occur in 1 to 10 people out of 1,000);
  • unknown (frequency cannot be estimated from the available data).

Common:
headache, drowsiness, nausea, dizziness.
Uncommon:
feeling of fatigue/somnolence.
Unknown:
difficulty sleeping (insomnia), sleep disturbances, nightmares/vivid dreams, nervousness,
irregular or rapid heartbeat, diarrhoea, skin rash and itching, urticaria, severe
allergic reactions (with symptoms such as: swelling of the face, lips, tongue or throat, sudden
reddening of the skin, chest tightness, and difficulty breathing).

Reporting of adverse reactions
If any adverse reactions occur, including any adverse reactions not listed in this leaflet, inform your doctor or pharmacist. Adverse reactions can be reported
directly to the Department of Monitoring of Adverse Drug Reactions of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Adverse reactions can also be reported to the marketing authorization holder.
Reporting adverse reactions helps to provide more information on the safety of the medicine.

5. How to store Fexofast 120 mg and Fexofast 180 mg

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the stated month.
There are no special storage instructions for this medicine.
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer in use. Such measures will help protect the environment.

6. Contents of the pack and other information

What Fexofast 120 mg contains

  • The active substance is fexofenadine hydrochloride. Each tablet contains 120 mg of fexofenadine hydrochloride, equivalent to 112 mg of fexofenadine.
  • Other ingredients are: tablet core: microcrystalline cellulose, sodium croscarmellose, maize starch, povidone, magnesium stearate; coating (Opadry 03C54667 Pink): hypromellose 6 cP (E 464), titanium dioxide (E 171), polyethylene glycol 400, polyethylene glycol 4000, yellow iron oxide (E 172), red iron oxide (E 172).

What Fexofast 180 mg contains

  • The active substance is fexofenadine hydrochloride. Each tablet contains 180 mg of fexofenadine hydrochloride, equivalent to 168 mg of fexofenadine.
  • Other ingredients are: tablet core: microcrystalline cellulose, sodium croscarmellose, maize starch, povidone, magnesium stearate; coating (Opadry 03C52662 Yellow): hypromellose 6 cP (E 464), titanium dioxide (E 171), polyethylene glycol 400, polyethylene glycol 4000, yellow iron oxide (E 172).

What Fexofast 120 mg looks like and contents of the pack
Fexofast 120 mg are peach-coloured, elongated, coated tablets, smooth on both sides.

What Fexofast 180 mg looks like and contents of the pack
Fexofast 180 mg are yellow, elongated, coated tablets, smooth on one side and with a central dividing line on the other side.

The pack of Fexofast 120 mg and Fexofast 180 mg may contain 7, 10, 20, or 30 tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder
PHARMALAB POLAND Sp. z o.o.
ul. Siemianowicka 84
41-902 Bytom
Poland

Manufacturer
Chanelle Medical Unlimited Company
Loughrea, Co. Galway
Ireland

Similar drugs

Brand name Dosage form Active substance / Dosage Manufacturer
ALLEGRA tablets, film-coated Opella Healthcare Italy S.r.l.
ALLEGRA TELFAST 180 tablets, film-coated Opella Healthcare Spain, S.L.
ALLEGRA TELFAST 180 tablets, film-coated Opella Healthcare Spain, S.L.
ALLEGRA TELFAST 180 tablets, film-coated Opella Healthcare Spain, S.L.
ALLERTEC FEXO tablets, film-coated Farmaprojects S.A.U. Pharmaceutical Plants POLPHARMA S.A.
FEXAHIST tablets, film-coated APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
FEXAHIST ALLERGY tablets, film-coated APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
FEXOFAST 120 MG tablets, film-coated Chanelle Medical Unlimited Company
FEXOFENADINE HYDROCHLORIDE CIPLA tablets, film-coated Cipla Europe NV Orion Corporation S&D Pharma CZ, spol. s r.o.
FEXOFENADINE HYDROCHLORIDE CIPLA tablets, film-coated Cipla Europe NV S&D Pharma CZ, s.r.o.
FEXOFENADINE HYDROCHLORIDE POLPHARMA tablets, film-coated US Pharmacia Sp. z o.o.
TELFAST 30 tablets, film-coated Sanofi Winthrop Industrie Sanofi-Aventis S.p.A.

The original data is available in the language of the country of manufacture.

Data source: Register of Medicinal Products of Poland (URPL)

Data last verified: September 01, 2026